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Abstract
Prostaglandin E2 (PGE2) is an inflammatory mediator capable of regulating fibroblast cell proliferation, matrix protein
production, and system A amino acid transport. System x3c amino acid transport is regulated by electrophilic agents and
oxygen. The effect of PGE2 on the x3c system transport of cystine and the synthesis of glutathione by human lung fibroblasts
was examined. Preincubation of fibroblast cultures with PGE2 decreased cystine uptake by 42%. Kinetic studies revealed a
42% decrease in the Vmax of the x3c system transporter in PGE2-treated fibroblasts ; however, the apparent Km was not
affected. The glutathione content of PGE2-treated fibroblasts was decreased by up to 25% of control. These results
demonstrate that system x3c transport of cystine is regulated by PGE2 and suggest that the limited availability of intracellular
cysteine inhibited glutathione synthesis. ß 1998 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The transport of amino acids across the mamma-
lian cell membrane is mediated by speci¢c amino
acid transport systems [1]. Transport systems exhibit
broad and overlapping substrate speci¢city. Most cell
types express the Na-independent transport system
L and the Na-dependent transport systems A and
ASC. System L transports branch-chain amino acids
whereas systems A and ASC transport aliphatic ami-
no acids. Di¡erent cell types may express additional
transport systems. Fibroblasts express system ASC
for the transport of alanine, serine, and cysteine [2].
Fibroblasts also express system x3c , a Na
-indepen-
dent system highly speci¢c for cystine and glutamate
[3^5]. A variety of substances and cell culture con-
ditions can regulate amino acid transport systems [1].
Prostaglandin E2 (PGE2) was shown previously to
regulate system A amino acid transport by intact
cells [6]. In lung ¢broblasts, PGE2 decreased the
transport of proline and aminoisobutyric acid by sys-
tem A; however, the transport of leucine by system L
was not a¡ected [6]. In hepatic plasma membrane
vesicles, PGE2 increased the transport of alanine by
system A and glutamine by system N [7] and the
Na-independent transport of arginine by system
y [8].
Human lung ¢broblasts transport cystine almost
exclusively by the x3c system in which the in£ux of
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cystine is coupled to the e¥ux of glutamate [3^5].
Following uptake, cystine is rapidly reduced to cys-
teine in the intracellular space [9,10]. The disul¢de
form, cystine, is predominant outside the cell where-
as the sulfhydryl form, cysteine, is predominant in-
side the cell. Cysteine is present at very low concen-
tration in the extracellular space and may be
transported directly by the ASC system.
Intracellular cysteine is necessary for the synthesis
of proteins, glutathione, and a variety of bioactive
metabolites. Glutathione synthesis is limited by the
availability of intracellular cysteine and is regulated
by changes in cystine transport activity [2,11^13].
Cystine transport by system x3c is induced by ¢bro-
blasts incubated in electrophilic agents [14] and by
endothelial cells [15], macrophages [16], and ¢bro-
blasts [17] exposed to hyperoxia. Cystine also regu-
lates the synthesis of K1(I) collagen mRNA by ¢bro-
blasts [18]. In humans, low plasma cystine levels are
associated with human immunode¢ciency virus infec-
tion, cancer, and senescence [19].
In these studies, the e¡ect of PGE2 on cystine up-
take and glutathione synthesis by human lung ¢bro-
blasts was examined. Preincubation of ¢broblast cul-
tures with PGE2 decreased cystine uptake and
glutathione synthesis; however, cysteine uptake was
not a¡ected.
2. Materials and methods
2.1. Cells and tissue cultures
Human embryonic lung ¢broblasts (IMR-90, Insti-
tute for Medical Research, Camden, NJ) were grown
in Dulbecco’s modi¢ed Eagle’s medium (DMEM)
with 0.37 g sodium bicarbonate/100 ml, 10% fetal
bovine serum, 100 U penicillin/ml, 10 Wg streptomy-
cin/ml, 1 mM sodium pyruvate, and 0.1 mM non-
essential amino acids. After con£uence was reached,
the serum content of the medium was reduced to
0.4%. Cell numbers were determined in triplicate
with an electronic particle counter (Coulter Counter
ZM).
2.2. Cystine transport
Fibroblasts were incubated in fresh medium de¢-
cient in all amino acids except labeled cystine for the
indicated time periods at 37‡C [6]. The incubation
was terminated by rinsing the cells three times with
cold Puck’s saline. Following the incubation, the cel-
lular material was extracted with 1 ml of 10% tri-
chloroacetic acid. The amount of trichloroacetic
acid-soluble labeled cystine was determined by scin-
tillation counting. The trichloroacetic acid-insoluble
fraction was used for protein determinations [6].
2.3. Glutathione assay
Fibroblasts were trypsinized, counted and resus-
pended. Proteins were precipitated by the addition
of 0.5% perchloric acid, sonication and centrifuga-
tion at 3000Ug for 20 min at 4‡C. The supernatants
were adjusted to pH 7 with 1 M KOH/0.3 M MOPS
and centrifuged at 10 000Ug for 5 min at 4‡C. The
glutathione content was determined by a colorimetric
assay using the method of Tietze [20] with modi¢-
cations described by Akerboom and Sies [21]. Each
assay was calibrated with standard glutathione.
Glutathione content was expressed as nmol per 106
cells.
2.4. Statistics
A Student’s t-test was used for means of unequal
size [22]. Probability values less than 0.05 were con-
sidered signi¢cant.
3. Results
The e¡ect of PGE2 on cystine uptake by human
lung ¢broblasts was examined using ¢broblast cul-
tures incubated in medium containing PGE2
(0.1 WM) for 24 h. In quiescent lung ¢broblast cul-
tures, the uptake of [35S]cystine remained linear for
at least 10 min (Fig. 1). Preincubation of the ¢bro-
blast cultures with PGE2 decreased [35S]cystine up-
take by 42% (P6 0.01) at 10 min.
The e¡ect of PGE2 on cysteine uptake by human
lung ¢broblasts was examined in similar experiments.
As noted previously, cysteine is transported primarily
by system ASC. In quiescent lung ¢broblast cultures,
the uptake of [35S]cysteine also remained linear for at
least 10 min (Fig. 2). Preincubation of the ¢broblast
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cultures with PGE2, however, did not a¡ect
[35S]cysteine uptake.
To assess the dose^response relation of PGE2 on
cystine uptake by human lung ¢broblasts, ¢broblast
cultures were incubated in medium containing PGE2
at various concentrations for 24 h and the uptake of
[35S]cystine was determined. Preincubation of the ¢-
broblast cultures with increasing concentrations of
PGE2 resulted in dose-dependent decreases in
[35S]cystine uptake (Fig. 3). The uptake at 0.01 WM,
0.1 WM, and 1 WM was decreased by 12%, 46%, and
68% of control, respectively.
The e¡ect of PGE2 on cystine uptake by human
lung ¢broblasts was examined further using kinetic
studies. Fibroblast cultures were incubated in me-
dium containing PGE2 (0.1 WM) for 24 h and the
uptake of [35S]cystine at various concentrations was
determined after 10 min. Preincubation of the ¢bro-
blast cultures with PGE2 resulted in a 42% decrease
in the Vmax, but had no e¡ect on the apparent Km
(Fig. 4). The Vmax in control and PGE2-treated cul-
tures were 1.27 and 0.74 nmol/min per mg protein,
respectively. The apparent Km in control and PGE2-
treated cultures were 0.053 and 0.056 mM, respec-
tively.
The relation of cystine on glutathione synthesis by
human lung ¢broblasts was assessed using ¢broblast
cultures incubated in medium containing cystine at
various concentrations for 24 h. Fibroblast cultures
incubated in increasing concentrations of cystine (0 to
2 mM) resulted in concentration-dependent increases
in the glutathione content (Fig. 5). The glutathione
content of ¢broblast cultures incubated in DMEM
Fig. 1. E¡ect of PGE2 on cystine uptake by lung ¢broblasts.
Quiescent lung ¢broblast cultures were incubated in DMEM in
the presence (b) or absence (a) of PGE2 (0.1 WM) for 24 h.
The medium was replaced with amino acid de¢cient medium
containing [35S]cystine (1 WCi/mM) for the indicated time peri-
ods. The uptake of [35S]cystine was determined following the
extraction of cellular material with 10% trichloroacetic acid.
Data are expressed as cpm, mean þ 1 S.E.; n = 3.
Fig. 2. E¡ect of PGE2 on cysteine uptake by lung ¢broblasts.
Quiescent lung ¢broblast cultures were incubated in DMEM in
the presence (b) or absence (a) of PGE2 (0.1 WM) for 24 h.
The medium was replaced with amino acid de¢cient medium
containing [35S]cysteine (1 WCi/mM) for the indicated time peri-
ods. The uptake of [35S]cysteine was determined following the
extraction of cellular material with 10% trichloroacetic acid.
Data are expressed as cpm; n = 2.
Fig. 3. Dose^response relation of PGE2 on cystine uptake by
lung ¢broblasts. Quiescent lung ¢broblast cultures were incu-
bated in DMEM in the presence of PGE2 at the indicated con-
centrations for 24 h. The medium was replaced with amino
acid de¢cient medium containing [35S]cystine (1 WCi/mM) for 10
min. The uptake of [35S]cystine was determined following the
extraction of cellular material with 10% trichloroacetic acid.
Data are expressed as cpm; n = 2.
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(0.2 mM cystine) was 6.51 þ 0.24 nmol/106 cells
(mean þ 1 S.D.; n = 3).
Fibroblast cultures were then incubated in medium
containing PGE2 at various concentrations for 24 h
and the glutathione content was determined. Prein-
cubation of the ¢broblast cultures with increasing
concentrations of PGE2 resulted in progressive de-
creases in the glutathione content (Fig. 6). The glu-
tathione content at 0.1 WM and 1 WM was decreased
by 19% (P6 0.05) and 25% (P6 0.05) of control,
respectively.
4. Discussion
The addition of PGE2 to human lung ¢broblast
cultures decreased cystine uptake by the x3c system;
however, cysteine uptake by the ASC system was not
a¡ected. The uptake of cystine is dependent on the
activity of the x3c system in which extracellular cys-
tine is transported in exchange for intracellular glu-
tamate [3^5]. System x3c transport of cystine is in-
duced by electrophilic agents and hyperoxia [14^
18]; however, this is the ¢rst demonstration that it
is regulated by an in£ammatory mediator.
Cell membrane proteins involved in the transport
of amino acids have the same kinetic behavior as
enzymes. Kinetic studies of the x3c system revealed
a decrease in the Vmax in PGE2-treated ¢broblasts,
re£ecting a decrease in the number of functional x3c
transporters. The observed e¡ect may have been due
to the degradation of transport proteins or to the
activation of transport protein inhibitors. There
Fig. 5. Dose^response relation of cystine on glutathione synthe-
sis by lung ¢broblasts. Quiescent lung ¢broblast cultures were
incubated in DMEM containing cystine at the indicated concen-
trations for 24 h. The glutathione content was then determined
by a colorimetric assay. Data are expressed as nmol/106 cells,
mean þ S.D.; n=3.
Fig. 6. E¡ect of PGE2 on glutathione synthesis by lung ¢bro-
blasts. Quiescent lung ¢broblast cultures were incubated in
DMEM in the presence of PGE2 at the indicated concentra-
tions for 24 h. The glutathione content was then determined by
a colorimetric assay. Data are expressed as nmol/106 cells,
mean þ S.D.; n = 3.
Fig. 4. Reciprocal velocity of cystine uptake plotted against re-
ciprocal of cystine concentration (Lineweaver^Burk plot). Qui-
escent lung ¢broblast cultures were incubated in DMEM in the
presence (b) or absence (a) of PGE2 (0.1 WM) for 24 h. The
uptake of [35S]cystine was determined following the addition of
amino acid de¢cient medium containing [35S]cystine at the indi-
cated concentrations for 10 min. Velocity is expressed as nmol/
min per mg protein; n = 2. The Vmax in control and PGE2-
treated cultures were 1.27 and 0.74 nmol/min per mg protein,
respectively. The apparent Km in control and PGE2-treated cul-
tures were 0.053 and 0.056 mM, respectively.
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was no change in the apparent Km of the x3c system
in PGE2-treated ¢broblasts, indicating there was no
change in the a⁄nity of the x3c transporter for its
substrate cystine. The Vmax and the apparent Km of
the x3c system in untreated ¢broblasts were in agree-
ment with previous reports [14]. Interestingly, PGE2
inhibits system A transport of amino acids by ¢bro-
blasts primarily by increases in the apparent Km and
not by changes in the Vmax [6].
The synthesis of glutathione was shown to be de-
pendent on the extracellular concentration of cystine.
Following uptake, cystine is rapidly reduced to cys-
teine which then becomes available for glutathione
synthesis. Glutathione synthesis is regulated by alter-
ations in the activity of the x3c system transport of
cystine [11^13]. The current data suggest that ¢bro-
blasts treated with PGE2 decreased glutathione syn-
thesis as a result of system x3c inhibition and the
subsequent decrease in intracellular cysteine avail-
ability. In phytohemagglutinin-stimulated human
mononuclear cells, PGE2 decreased glutathione syn-
thesis; however, the mechanism was not elucidated
[23]. The decreased uptake of cystine may have ac-
counted for the observed e¡ect.
The synthesis of PGE2 from arachidonic acid in-
volves reactions catalyzed by prostaglandin H syn-
thase and subsequently by glutathione-dependent
PGE2 isomerases [24^28]. Glutathione depletion in-
hibits PGE2 synthesis by ¢broblasts [29]. Oxidant
stress also decreases PGE2 synthesis and this e¡ect
is enhanced by depleting intracellular glutathione
[29]. It is possible that PGE2-induced depletion of
glutathione may limit further PGE2 synthesis. The
role of glutathione as a mediator in the feedback
inhibition of PGE2 is currently under investigation.
In summary, these studies demonstrate that PGE2
inhibited system x3c transport of cystine by human
lung ¢broblasts and suggest that the limited avail-
ability of intracellular cysteine inhibited glutathione
synthesis.
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